These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10260321)

  • 21. Comments of the American College of Pathologists on proposed regulations on payment for physician services in institutional practice.
    Pathologist; 1982 Dec; 36(12):suppl ii-xii. PubMed ID: 10261169
    [No Abstract]   [Full Text] [Related]  

  • 22. Pathologists to challenge Medicare rule.
    Lewis R
    Am Med News; 1983 Apr; 26(14):1, 19. PubMed ID: 10324806
    [No Abstract]   [Full Text] [Related]  

  • 23. A cost containment checklist.
    Garcia LS
    MLO Med Lab Obs; 1985 Apr; 17(4):67-8, 71-5. PubMed ID: 10270788
    [No Abstract]   [Full Text] [Related]  

  • 24. Surviving prospective reimbursement: how computers can help contain lab costs.
    Aller RD
    Pathologist; 1985 Apr; 39(4):12-6. PubMed ID: 10317589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The coming of Medicare--a turbulent time for pathology: Part II.
    Coleman FC
    Pathologist; 1981 May; 35(5):272-6. PubMed ID: 10298172
    [No Abstract]   [Full Text] [Related]  

  • 26. Controlling compensation for hospital-based pathologists.
    Van Vorst CB
    Case Stud Health Adm; 1980; 2():317-22. PubMed ID: 10250520
    [No Abstract]   [Full Text] [Related]  

  • 27. What the new Medicare rules mean to pathologists.
    Cole GW
    MLO Med Lab Obs; 1983 May; 15(5):50-4. PubMed ID: 10299168
    [No Abstract]   [Full Text] [Related]  

  • 28. The prognosis for the hospital-based pathologist--Part 1.
    Bierig JR
    Pathologist; 1986 Jul; 40(7):30-3. PubMed ID: 10277744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calling it like it is: reimbursement narcosis.
    Schoen I
    Pathologist; 1984 Nov; 38(11):747-8. PubMed ID: 10273593
    [No Abstract]   [Full Text] [Related]  

  • 30. TEFRA: a primer for the uninitiated.
    Kenety WH
    Pathologist; 1983 Sep; 37(9):655-8. PubMed ID: 10299327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Competition for the health dollar: the pathologist's share.
    Olsen HV
    Pathologist; 1983 Feb; 37(2):122-4. PubMed ID: 10261175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is that new instrument a winner?
    Stafford AC
    MLO Med Lab Obs; 1986 Apr; 18(4):24-8. PubMed ID: 10317714
    [No Abstract]   [Full Text] [Related]  

  • 33. Despite ongoing challenges, pathologist reimbursement rules take effect.
    MLO Med Lab Obs; 1984 Mar; 16(3):27, 29. PubMed ID: 10273470
    [No Abstract]   [Full Text] [Related]  

  • 34. How to manage under prospective payment.
    Sisk FA
    MLO Med Lab Obs; 1987 Apr; 19(4):71-4. PubMed ID: 10312034
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost analysis: strep only culture.
    McConnell TS; Fuller WD
    Rocky Mt Med J; 1978; 75(4):207-8. PubMed ID: 356166
    [No Abstract]   [Full Text] [Related]  

  • 36. Benefits of costing in the clinical laboratory.
    Broughton PM; Woodford FP
    J Clin Pathol; 1983 Sep; 36(9):1028-35. PubMed ID: 6886020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathologist fee crisis--Rx for relief.
    Healy MI
    Case Stud Health Adm; 1980; 2():312-6. PubMed ID: 10250519
    [No Abstract]   [Full Text] [Related]  

  • 38. Administrator and pathologist conflict in contract negotiations.
    Milligan WM
    Case Stud Health Adm; 1980; 2():307-11. PubMed ID: 10250518
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathology practice under TEFRA and DRGs.
    Breckenridge RL
    Pathologist; 1983 Aug; 37(8):560-2. PubMed ID: 10310298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Teaming up with administrators to set prospective payment policy.
    Shaw LD
    Pathologist; 1984 Jun; 38(6):352-3. PubMed ID: 10273529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.